Earnings Call · Q2 FY2023·2023-08-10

Q2 23EPS -11.11%·Rev n/aQ1 23EPS +10.00%·Rev n/aQ4 22EPS -35.71%·Rev n/aQ3 22EPS +29.41%·Rev n/a⚠ consensus missing

Dare Bioscience, Inc. DARE

Sabrina Martucci Johnson — Chief Executive Officer

John Fair — Chief Medical Officer

Lisa Walters-Hoffert — Chief Financial Officer

−2.3%1d on move date−2.3% vs SPY3d+1.6%5d−0.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more DARE calls or request research access.

More DARE calls Browse calls Request research access